Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy (FPHAF) Stock Competitors & Peer Comparison
See (FPHAF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| FPHAF | $3.30 | +0.00% | 209.5M | -7.50 | -$0.44 | N/A |
| NONOF | $69.94 | -0.19% | 320.7B | 19.58 | $3.69 | +2.37% |
| CSLLY | $88.17 | -0.92% | 170.8B | 32.29 | $2.73 | +1.50% |
| CMXHF | $175.70 | -1.19% | 85.1B | 32.18 | $5.46 | +1.52% |
| UCBJF | $213.55 | +1.62% | 41.2B | 33.99 | $6.37 | +0.73% |
| UCBJY | $105.14 | +0.11% | 39.9B | 32.73 | $3.21 | +0.75% |
| ARGNF | $547.60 | +0.00% | 33.5B | 33.45 | $16.37 | N/A |
| ODTC | $22,005.00 | +29.44% | 24.1B | 1.07 | $20,580.00 | N/A |
| IVBXF | $11.50 | +0.00% | 19.7B | -1150.00 | -$0.01 | N/A |
| WXIBF | $4.00 | +5.26% | 16.3B | 36.36 | $0.11 | N/A |
Stock Comparison
FPHAF vs NONOF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, NONOF has a market cap of 320.7B. Regarding current trading prices, FPHAF is priced at $3.30, while NONOF trades at $69.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas NONOF's P/E ratio is 19.58. In terms of profitability, FPHAF's ROE is N/A, compared to NONOF's ROE of +0.81%. Regarding short-term risk, FPHAF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check NONOF's competition here
FPHAF vs CSLLY Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CSLLY has a market cap of 170.8B. Regarding current trading prices, FPHAF is priced at $3.30, while CSLLY trades at $88.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CSLLY's P/E ratio is 32.29. In terms of profitability, FPHAF's ROE is N/A, compared to CSLLY's ROE of +0.26%. Regarding short-term risk, FPHAF is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check CSLLY's competition here
FPHAF vs CMXHF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CMXHF has a market cap of 85.1B. Regarding current trading prices, FPHAF is priced at $3.30, while CMXHF trades at $175.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CMXHF's P/E ratio is 32.18. In terms of profitability, FPHAF's ROE is N/A, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, FPHAF is less volatile compared to CMXHF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check CMXHF's competition here
FPHAF vs UCBJF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, UCBJF has a market cap of 41.2B. Regarding current trading prices, FPHAF is priced at $3.30, while UCBJF trades at $213.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas UCBJF's P/E ratio is 33.99. In terms of profitability, FPHAF's ROE is N/A, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, FPHAF is less volatile compared to UCBJF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check UCBJF's competition here
FPHAF vs UCBJY Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, UCBJY has a market cap of 39.9B. Regarding current trading prices, FPHAF is priced at $3.30, while UCBJY trades at $105.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas UCBJY's P/E ratio is 32.73. In terms of profitability, FPHAF's ROE is N/A, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, FPHAF is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check UCBJY's competition here
FPHAF vs ARGNF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ARGNF has a market cap of 33.5B. Regarding current trading prices, FPHAF is priced at $3.30, while ARGNF trades at $547.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ARGNF's P/E ratio is 33.45. In terms of profitability, FPHAF's ROE is N/A, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, FPHAF is less volatile compared to ARGNF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check ARGNF's competition here
FPHAF vs ODTC Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ODTC has a market cap of 24.1B. Regarding current trading prices, FPHAF is priced at $3.30, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ODTC's P/E ratio is 1.07. In terms of profitability, FPHAF's ROE is N/A, compared to ODTC's ROE of +0.07%. Regarding short-term risk, FPHAF and ODTC have similar daily volatility (0.00).Check ODTC's competition here
FPHAF vs IVBXF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, IVBXF has a market cap of 19.7B. Regarding current trading prices, FPHAF is priced at $3.30, while IVBXF trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas IVBXF's P/E ratio is -1150.00. In terms of profitability, FPHAF's ROE is N/A, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, FPHAF is less volatile compared to IVBXF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check IVBXF's competition here
FPHAF vs WXIBF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, WXIBF has a market cap of 16.3B. Regarding current trading prices, FPHAF is priced at $3.30, while WXIBF trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas WXIBF's P/E ratio is 36.36. In terms of profitability, FPHAF's ROE is N/A, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, FPHAF and WXIBF have similar daily volatility (0.00).Check WXIBF's competition here
FPHAF vs WXXWY Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, WXXWY has a market cap of 16.2B. Regarding current trading prices, FPHAF is priced at $3.30, while WXXWY trades at $7.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas WXXWY's P/E ratio is 36.23. In terms of profitability, FPHAF's ROE is N/A, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, FPHAF is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check WXXWY's competition here
FPHAF vs SBMFF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SBMFF has a market cap of 16B. Regarding current trading prices, FPHAF is priced at $3.30, while SBMFF trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SBMFF's P/E ratio is 89.21. In terms of profitability, FPHAF's ROE is N/A, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, FPHAF and SBMFF have similar daily volatility (0.00).Check SBMFF's competition here
FPHAF vs SBHMY Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SBHMY has a market cap of 15.6B. Regarding current trading prices, FPHAF is priced at $3.30, while SBHMY trades at $17.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SBHMY's P/E ratio is 60.34. In terms of profitability, FPHAF's ROE is N/A, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, FPHAF and SBHMY have similar daily volatility (0.00).Check SBHMY's competition here
FPHAF vs GNMSF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, GNMSF has a market cap of 14B. Regarding current trading prices, FPHAF is priced at $3.30, while GNMSF trades at $226.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas GNMSF's P/E ratio is 13.32. In terms of profitability, FPHAF's ROE is N/A, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, FPHAF and GNMSF have similar daily volatility (0.00).Check GNMSF's competition here
FPHAF vs TRSBF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, TRSBF has a market cap of 8.8B. Regarding current trading prices, FPHAF is priced at $3.30, while TRSBF trades at $3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas TRSBF's P/E ratio is 31.00. In terms of profitability, FPHAF's ROE is N/A, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, FPHAF and TRSBF have similar daily volatility (0.00).Check TRSBF's competition here
FPHAF vs AKBLF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, AKBLF has a market cap of 6.8B. Regarding current trading prices, FPHAF is priced at $3.30, while AKBLF trades at $30.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas AKBLF's P/E ratio is 46.83. In terms of profitability, FPHAF's ROE is N/A, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, FPHAF is less volatile compared to AKBLF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check AKBLF's competition here
FPHAF vs ABCZF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, FPHAF is priced at $3.30, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, FPHAF's ROE is N/A, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, FPHAF and ABCZF have similar daily volatility (0.00).Check ABCZF's competition here
FPHAF vs GNNSF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, GNNSF has a market cap of 5B. Regarding current trading prices, FPHAF is priced at $3.30, while GNNSF trades at $2.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas GNNSF's P/E ratio is -28.83. In terms of profitability, FPHAF's ROE is N/A, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, FPHAF and GNNSF have similar daily volatility (0.00).Check GNNSF's competition here
FPHAF vs INCPF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, INCPF has a market cap of 4.9B. Regarding current trading prices, FPHAF is priced at $3.30, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas INCPF's P/E ratio is -108.67. In terms of profitability, FPHAF's ROE is N/A, compared to INCPF's ROE of -0.05%. Regarding short-term risk, FPHAF and INCPF have similar daily volatility (0.00).Check INCPF's competition here
FPHAF vs LABFF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, FPHAF is priced at $3.30, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas LABFF's P/E ratio is 28.95. In terms of profitability, FPHAF's ROE is N/A, compared to LABFF's ROE of +0.38%. Regarding short-term risk, FPHAF and LABFF have similar daily volatility (0.00).Check LABFF's competition here
FPHAF vs TLPPF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, TLPPF has a market cap of 4.6B. Regarding current trading prices, FPHAF is priced at $3.30, while TLPPF trades at $13.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas TLPPF's P/E ratio is 150.00. In terms of profitability, FPHAF's ROE is N/A, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, FPHAF is less volatile compared to TLPPF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check TLPPF's competition here
FPHAF vs AAVXF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, AAVXF has a market cap of 4.4B. Regarding current trading prices, FPHAF is priced at $3.30, while AAVXF trades at $68.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas AAVXF's P/E ratio is -19.88. In terms of profitability, FPHAF's ROE is N/A, compared to AAVXF's ROE of -2.11%. Regarding short-term risk, FPHAF and AAVXF have similar daily volatility (0.00).Check AAVXF's competition here
FPHAF vs ZLDPF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ZLDPF has a market cap of 4.3B. Regarding current trading prices, FPHAF is priced at $3.30, while ZLDPF trades at $61.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ZLDPF's P/E ratio is -22.70. In terms of profitability, FPHAF's ROE is N/A, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, FPHAF and ZLDPF have similar daily volatility (0.00).Check ZLDPF's competition here
FPHAF vs CAMRF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CAMRF has a market cap of 4.2B. Regarding current trading prices, FPHAF is priced at $3.30, while CAMRF trades at $71.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CAMRF's P/E ratio is 56.35. In terms of profitability, FPHAF's ROE is N/A, compared to CAMRF's ROE of +0.17%. Regarding short-term risk, FPHAF is less volatile compared to CAMRF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check CAMRF's competition here
FPHAF vs SHJBF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SHJBF has a market cap of 3.1B. Regarding current trading prices, FPHAF is priced at $3.30, while SHJBF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SHJBF's P/E ratio is -10.94. In terms of profitability, FPHAF's ROE is N/A, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, FPHAF is less volatile compared to SHJBF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check SHJBF's competition here
FPHAF vs REGMF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, REGMF has a market cap of 3B. Regarding current trading prices, FPHAF is priced at $3.30, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas REGMF's P/E ratio is -13.32. In terms of profitability, FPHAF's ROE is N/A, compared to REGMF's ROE of -0.48%. Regarding short-term risk, FPHAF is less volatile compared to REGMF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check REGMF's competition here
FPHAF vs BVNRY Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BVNRY has a market cap of 2.8B. Regarding current trading prices, FPHAF is priced at $3.30, while BVNRY trades at $12.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BVNRY's P/E ratio is 13.83. In terms of profitability, FPHAF's ROE is N/A, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, FPHAF is less volatile compared to BVNRY. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check BVNRY's competition here
FPHAF vs BVNKF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BVNKF has a market cap of 2.8B. Regarding current trading prices, FPHAF is priced at $3.30, while BVNKF trades at $36.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BVNKF's P/E ratio is 13.85. In terms of profitability, FPHAF's ROE is N/A, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, FPHAF is less volatile compared to BVNKF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check BVNKF's competition here
FPHAF vs TKBIF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, TKBIF has a market cap of 2.8B. Regarding current trading prices, FPHAF is priced at $3.30, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, FPHAF's ROE is N/A, compared to TKBIF's ROE of N/A. Regarding short-term risk, FPHAF and TKBIF have similar daily volatility (0.00).Check TKBIF's competition here
FPHAF vs MPSYF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, FPHAF is priced at $3.30, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, FPHAF's ROE is N/A, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, FPHAF is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check MPSYF's competition here
FPHAF vs ONTTF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ONTTF has a market cap of 2.7B. Regarding current trading prices, FPHAF is priced at $3.30, while ONTTF trades at $2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ONTTF's P/E ratio is -12.78. In terms of profitability, FPHAF's ROE is N/A, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, FPHAF is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check ONTTF's competition here
FPHAF vs ASPHF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ASPHF has a market cap of 2B. Regarding current trading prices, FPHAF is priced at $3.30, while ASPHF trades at $5.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ASPHF's P/E ratio is -32.36. In terms of profitability, FPHAF's ROE is N/A, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, FPHAF and ASPHF have similar daily volatility (0.00).Check ASPHF's competition here
FPHAF vs IUGNF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, IUGNF has a market cap of 1.9B. Regarding current trading prices, FPHAF is priced at $3.30, while IUGNF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas IUGNF's P/E ratio is -26.00. In terms of profitability, FPHAF's ROE is N/A, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, FPHAF is less volatile compared to IUGNF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check IUGNF's competition here
FPHAF vs BTTAY Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BTTAY has a market cap of 1.9B. Regarding current trading prices, FPHAF is priced at $3.30, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, FPHAF's ROE is N/A, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, FPHAF is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check BTTAY's competition here
FPHAF vs GLPGF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, GLPGF has a market cap of 1.9B. Regarding current trading prices, FPHAF is priced at $3.30, while GLPGF trades at $28.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas GLPGF's P/E ratio is -5.57. In terms of profitability, FPHAF's ROE is N/A, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, FPHAF is less volatile compared to GLPGF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check GLPGF's competition here
FPHAF vs BRCTF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BRCTF has a market cap of 1.7B. Regarding current trading prices, FPHAF is priced at $3.30, while BRCTF trades at $19.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BRCTF's P/E ratio is 18.07. In terms of profitability, FPHAF's ROE is N/A, compared to BRCTF's ROE of +0.77%. Regarding short-term risk, FPHAF is less volatile compared to BRCTF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check BRCTF's competition here
FPHAF vs GENSF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, GENSF has a market cap of 1.7B. Regarding current trading prices, FPHAF is priced at $3.30, while GENSF trades at $26.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas GENSF's P/E ratio is -325.12. In terms of profitability, FPHAF's ROE is N/A, compared to GENSF's ROE of +0.01%. Regarding short-term risk, FPHAF and GENSF have similar daily volatility (0.00).Check GENSF's competition here
FPHAF vs BIESF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, FPHAF is priced at $3.30, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BIESF's P/E ratio is -44.44. In terms of profitability, FPHAF's ROE is N/A, compared to BIESF's ROE of +0.05%. Regarding short-term risk, FPHAF and BIESF have similar daily volatility (0.00).Check BIESF's competition here
FPHAF vs PHMMF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PHMMF has a market cap of 1.6B. Regarding current trading prices, FPHAF is priced at $3.30, while PHMMF trades at $92.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PHMMF's P/E ratio is 70.13. In terms of profitability, FPHAF's ROE is N/A, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, FPHAF is less volatile compared to PHMMF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check PHMMF's competition here
FPHAF vs PPTDF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PPTDF has a market cap of 1.5B. Regarding current trading prices, FPHAF is priced at $3.30, while PPTDF trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PPTDF's P/E ratio is 15.52. In terms of profitability, FPHAF's ROE is N/A, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, FPHAF and PPTDF have similar daily volatility (0.00).Check PPTDF's competition here
FPHAF vs CSBTF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CSBTF has a market cap of 1.4B. Regarding current trading prices, FPHAF is priced at $3.30, while CSBTF trades at $36.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CSBTF's P/E ratio is -277.15. In terms of profitability, FPHAF's ROE is N/A, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, FPHAF and CSBTF have similar daily volatility (0.00).Check CSBTF's competition here
FPHAF vs NURPF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, NURPF has a market cap of 1.4B. Regarding current trading prices, FPHAF is priced at $3.30, while NURPF trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas NURPF's P/E ratio is 15.49. In terms of profitability, FPHAF's ROE is N/A, compared to NURPF's ROE of +0.49%. Regarding short-term risk, FPHAF is less volatile compared to NURPF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check NURPF's competition here
FPHAF vs ASCLF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ASCLF has a market cap of 1.3B. Regarding current trading prices, FPHAF is priced at $3.30, while ASCLF trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ASCLF's P/E ratio is -34.50. In terms of profitability, FPHAF's ROE is N/A, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, FPHAF is less volatile compared to ASCLF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check ASCLF's competition here
FPHAF vs BRAXF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BRAXF has a market cap of 1.3B. Regarding current trading prices, FPHAF is priced at $3.30, while BRAXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BRAXF's P/E ratio is -0.03. In terms of profitability, FPHAF's ROE is N/A, compared to BRAXF's ROE of -2.49%. Regarding short-term risk, FPHAF is less volatile compared to BRAXF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check BRAXF's competition here
FPHAF vs MEOBF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, MEOBF has a market cap of 1.2B. Regarding current trading prices, FPHAF is priced at $3.30, while MEOBF trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas MEOBF's P/E ratio is -16.17. In terms of profitability, FPHAF's ROE is N/A, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, FPHAF is less volatile compared to MEOBF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check MEOBF's competition here
FPHAF vs SNBIF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SNBIF has a market cap of 1B. Regarding current trading prices, FPHAF is priced at $3.30, while SNBIF trades at $14.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SNBIF's P/E ratio is -34.83. In terms of profitability, FPHAF's ROE is N/A, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, FPHAF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check SNBIF's competition here
FPHAF vs HBMHF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, HBMHF has a market cap of 931.6M. Regarding current trading prices, FPHAF is priced at $3.30, while HBMHF trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas HBMHF's P/E ratio is 36.67. In terms of profitability, FPHAF's ROE is N/A, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, FPHAF is less volatile compared to HBMHF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check HBMHF's competition here
FPHAF vs CSPHF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CSPHF has a market cap of 910.9M. Regarding current trading prices, FPHAF is priced at $3.30, while CSPHF trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CSPHF's P/E ratio is -62.50. In terms of profitability, FPHAF's ROE is N/A, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, FPHAF is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check CSPHF's competition here
FPHAF vs PHGUF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PHGUF has a market cap of 787.9M. Regarding current trading prices, FPHAF is priced at $3.30, while PHGUF trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PHGUF's P/E ratio is -57.50. In terms of profitability, FPHAF's ROE is N/A, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, FPHAF is less volatile compared to PHGUF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check PHGUF's competition here
FPHAF vs BPMUF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BPMUF has a market cap of 752.8M. Regarding current trading prices, FPHAF is priced at $3.30, while BPMUF trades at $61.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BPMUF's P/E ratio is 8.39. In terms of profitability, FPHAF's ROE is N/A, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, FPHAF is less volatile compared to BPMUF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check BPMUF's competition here
FPHAF vs IDRSF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, IDRSF has a market cap of 732.9M. Regarding current trading prices, FPHAF is priced at $3.30, while IDRSF trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas IDRSF's P/E ratio is -2.12. In terms of profitability, FPHAF's ROE is N/A, compared to IDRSF's ROE of +0.20%. Regarding short-term risk, FPHAF is less volatile compared to IDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check IDRSF's competition here
FPHAF vs INRLF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, INRLF has a market cap of 654.7M. Regarding current trading prices, FPHAF is priced at $3.30, while INRLF trades at $3.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas INRLF's P/E ratio is -5.92. In terms of profitability, FPHAF's ROE is N/A, compared to INRLF's ROE of -0.43%. Regarding short-term risk, FPHAF is less volatile compared to INRLF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check INRLF's competition here
FPHAF vs SOLTF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SOLTF has a market cap of 556.5M. Regarding current trading prices, FPHAF is priced at $3.30, while SOLTF trades at $6.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SOLTF's P/E ratio is -34.17. In terms of profitability, FPHAF's ROE is N/A, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, FPHAF and SOLTF have similar daily volatility (0.00).Check SOLTF's competition here
FPHAF vs CKDXF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CKDXF has a market cap of 486.7M. Regarding current trading prices, FPHAF is priced at $3.30, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, FPHAF's ROE is N/A, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, FPHAF is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check CKDXF's competition here
FPHAF vs RAONF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, FPHAF is priced at $3.30, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas RAONF's P/E ratio is -43.33. In terms of profitability, FPHAF's ROE is N/A, compared to RAONF's ROE of -0.71%. Regarding short-term risk, FPHAF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check RAONF's competition here
FPHAF vs TBGNF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, FPHAF is priced at $3.30, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, FPHAF's ROE is N/A, compared to TBGNF's ROE of N/A. Regarding short-term risk, FPHAF and TBGNF have similar daily volatility (0.00).Check TBGNF's competition here
FPHAF vs PTCHF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PTCHF has a market cap of 425.2M. Regarding current trading prices, FPHAF is priced at $3.30, while PTCHF trades at $1.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PTCHF's P/E ratio is 8.43. In terms of profitability, FPHAF's ROE is N/A, compared to PTCHF's ROE of +0.15%. Regarding short-term risk, FPHAF is less volatile compared to PTCHF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check PTCHF's competition here
FPHAF vs CLVLF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CLVLF has a market cap of 401M. Regarding current trading prices, FPHAF is priced at $3.30, while CLVLF trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CLVLF's P/E ratio is 16.00. In terms of profitability, FPHAF's ROE is N/A, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, FPHAF and CLVLF have similar daily volatility (0.00).Check CLVLF's competition here
FPHAF vs VBIZF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, VBIZF has a market cap of 393.2M. Regarding current trading prices, FPHAF is priced at $3.30, while VBIZF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas VBIZF's P/E ratio is 18.90. In terms of profitability, FPHAF's ROE is N/A, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, FPHAF is less volatile compared to VBIZF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check VBIZF's competition here
FPHAF vs CLVLY Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CLVLY has a market cap of 388.5M. Regarding current trading prices, FPHAF is priced at $3.30, while CLVLY trades at $7.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CLVLY's P/E ratio is 15.50. In terms of profitability, FPHAF's ROE is N/A, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, FPHAF is less volatile compared to CLVLY. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check CLVLY's competition here
FPHAF vs CLTEF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CLTEF has a market cap of 387.7M. Regarding current trading prices, FPHAF is priced at $3.30, while CLTEF trades at $5.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CLTEF's P/E ratio is -5.42. In terms of profitability, FPHAF's ROE is N/A, compared to CLTEF's ROE of -0.43%. Regarding short-term risk, FPHAF and CLTEF have similar daily volatility (0.00).Check CLTEF's competition here
FPHAF vs NWBO Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, NWBO has a market cap of 377.6M. Regarding current trading prices, FPHAF is priced at $3.30, while NWBO trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas NWBO's P/E ratio is -4.32. In terms of profitability, FPHAF's ROE is N/A, compared to NWBO's ROE of +1.13%. Regarding short-term risk, FPHAF is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check NWBO's competition here
FPHAF vs HLOSF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, HLOSF has a market cap of 376M. Regarding current trading prices, FPHAF is priced at $3.30, while HLOSF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas HLOSF's P/E ratio is -11.08. In terms of profitability, FPHAF's ROE is N/A, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, FPHAF and HLOSF have similar daily volatility (0.00).Check HLOSF's competition here
FPHAF vs CYDY Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CYDY has a market cap of 367.9M. Regarding current trading prices, FPHAF is priced at $3.30, while CYDY trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CYDY's P/E ratio is -14.92. In terms of profitability, FPHAF's ROE is N/A, compared to CYDY's ROE of +0.07%. Regarding short-term risk, FPHAF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check CYDY's competition here
FPHAF vs IVEVF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, IVEVF has a market cap of 317.2M. Regarding current trading prices, FPHAF is priced at $3.30, while IVEVF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas IVEVF's P/E ratio is -0.66. In terms of profitability, FPHAF's ROE is N/A, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, FPHAF is less volatile compared to IVEVF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check IVEVF's competition here
FPHAF vs PBBIF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, FPHAF is priced at $3.30, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, FPHAF's ROE is N/A, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, FPHAF is less volatile compared to PBBIF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check PBBIF's competition here
FPHAF vs PRRUF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PRRUF has a market cap of 278.9M. Regarding current trading prices, FPHAF is priced at $3.30, while PRRUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PRRUF's P/E ratio is -9.50. In terms of profitability, FPHAF's ROE is N/A, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, FPHAF is less volatile compared to PRRUF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check PRRUF's competition here
FPHAF vs BXPHF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BXPHF has a market cap of 277.1M. Regarding current trading prices, FPHAF is priced at $3.30, while BXPHF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BXPHF's P/E ratio is -14.13. In terms of profitability, FPHAF's ROE is N/A, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, FPHAF is less volatile compared to BXPHF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check BXPHF's competition here
FPHAF vs ORYZF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ORYZF has a market cap of 254.2M. Regarding current trading prices, FPHAF is priced at $3.30, while ORYZF trades at $3.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ORYZF's P/E ratio is -46.86. In terms of profitability, FPHAF's ROE is N/A, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, FPHAF and ORYZF have similar daily volatility (0.00).Check ORYZF's competition here
FPHAF vs AVCTF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, AVCTF has a market cap of 246.5M. Regarding current trading prices, FPHAF is priced at $3.30, while AVCTF trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas AVCTF's P/E ratio is -5.79. In terms of profitability, FPHAF's ROE is N/A, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, FPHAF is less volatile compared to AVCTF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check AVCTF's competition here
FPHAF vs HNSBF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, HNSBF has a market cap of 232.3M. Regarding current trading prices, FPHAF is priced at $3.30, while HNSBF trades at $2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas HNSBF's P/E ratio is -3.04. In terms of profitability, FPHAF's ROE is N/A, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, FPHAF is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check HNSBF's competition here
FPHAF vs NWPHF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, NWPHF has a market cap of 231.2M. Regarding current trading prices, FPHAF is priced at $3.30, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas NWPHF's P/E ratio is N/A. In terms of profitability, FPHAF's ROE is N/A, compared to NWPHF's ROE of N/A. Regarding short-term risk, FPHAF and NWPHF have similar daily volatility (0.00).Check NWPHF's competition here
FPHAF vs MDCLF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, MDCLF has a market cap of 230.8M. Regarding current trading prices, FPHAF is priced at $3.30, while MDCLF trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, FPHAF's ROE is N/A, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, FPHAF is less volatile compared to MDCLF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check MDCLF's competition here
FPHAF vs SLNCF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SLNCF has a market cap of 226.7M. Regarding current trading prices, FPHAF is priced at $3.30, while SLNCF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SLNCF's P/E ratio is -3.14. In terms of profitability, FPHAF's ROE is N/A, compared to SLNCF's ROE of -0.87%. Regarding short-term risk, FPHAF is less volatile compared to SLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check SLNCF's competition here
FPHAF vs BOVNF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, FPHAF is priced at $3.30, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BOVNF's P/E ratio is -4.44. In terms of profitability, FPHAF's ROE is N/A, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, FPHAF is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check BOVNF's competition here
FPHAF vs VSBC Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, VSBC has a market cap of 207M. Regarding current trading prices, FPHAF is priced at $3.30, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas VSBC's P/E ratio is N/A. In terms of profitability, FPHAF's ROE is N/A, compared to VSBC's ROE of +0.00%. Regarding short-term risk, FPHAF and VSBC have similar daily volatility (0.00).Check VSBC's competition here
FPHAF vs FGHQF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, FGHQF has a market cap of 205.6M. Regarding current trading prices, FPHAF is priced at $3.30, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, FPHAF's ROE is N/A, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, FPHAF is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check FGHQF's competition here
FPHAF vs CAIHF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CAIHF has a market cap of 204.9M. Regarding current trading prices, FPHAF is priced at $3.30, while CAIHF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CAIHF's P/E ratio is 7.00. In terms of profitability, FPHAF's ROE is N/A, compared to CAIHF's ROE of +0.05%. Regarding short-term risk, FPHAF is less volatile compared to CAIHF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check CAIHF's competition here
FPHAF vs BSEM Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BSEM has a market cap of 192.8M. Regarding current trading prices, FPHAF is priced at $3.30, while BSEM trades at $11.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BSEM's P/E ratio is 8.03. In terms of profitability, FPHAF's ROE is N/A, compared to BSEM's ROE of +1.50%. Regarding short-term risk, FPHAF is less volatile compared to BSEM. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check BSEM's competition here
FPHAF vs SPHDF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SPHDF has a market cap of 190.7M. Regarding current trading prices, FPHAF is priced at $3.30, while SPHDF trades at $14.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SPHDF's P/E ratio is -3.19. In terms of profitability, FPHAF's ROE is N/A, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, FPHAF is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check SPHDF's competition here
FPHAF vs NGENF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, NGENF has a market cap of 186.6M. Regarding current trading prices, FPHAF is priced at $3.30, while NGENF trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas NGENF's P/E ratio is -9.14. In terms of profitability, FPHAF's ROE is N/A, compared to NGENF's ROE of -4.00%. Regarding short-term risk, FPHAF is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check NGENF's competition here
FPHAF vs CMVLF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CMVLF has a market cap of 186M. Regarding current trading prices, FPHAF is priced at $3.30, while CMVLF trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CMVLF's P/E ratio is -3.85. In terms of profitability, FPHAF's ROE is N/A, compared to CMVLF's ROE of -0.46%. Regarding short-term risk, FPHAF is less volatile compared to CMVLF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check CMVLF's competition here
FPHAF vs GNFTF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, GNFTF has a market cap of 185.2M. Regarding current trading prices, FPHAF is priced at $3.30, while GNFTF trades at $3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas GNFTF's P/E ratio is 93.00. In terms of profitability, FPHAF's ROE is N/A, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, FPHAF and GNFTF have similar daily volatility (0.00).Check GNFTF's competition here
FPHAF vs ADOCY Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, FPHAF is priced at $3.30, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, FPHAF's ROE is N/A, compared to ADOCY's ROE of +1.73%. Regarding short-term risk, FPHAF and ADOCY have similar daily volatility (0.00).Check ADOCY's competition here
FPHAF vs BRIBF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BRIBF has a market cap of 169.3M. Regarding current trading prices, FPHAF is priced at $3.30, while BRIBF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BRIBF's P/E ratio is -2.31. In terms of profitability, FPHAF's ROE is N/A, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, FPHAF is less volatile compared to BRIBF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check BRIBF's competition here
FPHAF vs OPORF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, OPORF has a market cap of 164.9M. Regarding current trading prices, FPHAF is priced at $3.30, while OPORF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas OPORF's P/E ratio is 12.00. In terms of profitability, FPHAF's ROE is N/A, compared to OPORF's ROE of +0.42%. Regarding short-term risk, FPHAF is less volatile compared to OPORF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check OPORF's competition here
FPHAF vs MLLCF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, MLLCF has a market cap of 155.6M. Regarding current trading prices, FPHAF is priced at $3.30, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas MLLCF's P/E ratio is -1.98. In terms of profitability, FPHAF's ROE is N/A, compared to MLLCF's ROE of -0.42%. Regarding short-term risk, FPHAF is less volatile compared to MLLCF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check MLLCF's competition here
FPHAF vs SCNLF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SCNLF has a market cap of 135.4M. Regarding current trading prices, FPHAF is priced at $3.30, while SCNLF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SCNLF's P/E ratio is -4.35. In terms of profitability, FPHAF's ROE is N/A, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, FPHAF is less volatile compared to SCNLF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check SCNLF's competition here
FPHAF vs AAPGV Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, FPHAF is priced at $3.30, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas AAPGV's P/E ratio is N/A. In terms of profitability, FPHAF's ROE is N/A, compared to AAPGV's ROE of -2.50%. Regarding short-term risk, FPHAF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check AAPGV's competition here
FPHAF vs AMGXF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, AMGXF has a market cap of 127.1M. Regarding current trading prices, FPHAF is priced at $3.30, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, FPHAF's ROE is N/A, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, FPHAF is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check AMGXF's competition here
FPHAF vs IPHYF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, IPHYF has a market cap of 120.7M. Regarding current trading prices, FPHAF is priced at $3.30, while IPHYF trades at $1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas IPHYF's P/E ratio is -1.82. In terms of profitability, FPHAF's ROE is N/A, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, FPHAF is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check IPHYF's competition here
FPHAF vs PSTTF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, FPHAF is priced at $3.30, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, FPHAF's ROE is N/A, compared to PSTTF's ROE of N/A. Regarding short-term risk, FPHAF and PSTTF have similar daily volatility (0.00).Check PSTTF's competition here
FPHAF vs EPRXF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, FPHAF is priced at $3.30, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, FPHAF's ROE is N/A, compared to EPRXF's ROE of -0.85%. Regarding short-term risk, FPHAF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check EPRXF's competition here
FPHAF vs ADOIF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, FPHAF is priced at $3.30, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, FPHAF's ROE is N/A, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, FPHAF and ADOIF have similar daily volatility (0.00).Check ADOIF's competition here
FPHAF vs JWCTF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, JWCTF has a market cap of 101.3M. Regarding current trading prices, FPHAF is priced at $3.30, while JWCTF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas JWCTF's P/E ratio is -1.25. In terms of profitability, FPHAF's ROE is N/A, compared to JWCTF's ROE of -0.47%. Regarding short-term risk, FPHAF and JWCTF have similar daily volatility (0.00).Check JWCTF's competition here
FPHAF vs TRGNF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, TRGNF has a market cap of 92.7M. Regarding current trading prices, FPHAF is priced at $3.30, while TRGNF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas TRGNF's P/E ratio is -2.06. In terms of profitability, FPHAF's ROE is N/A, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, FPHAF is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check TRGNF's competition here
FPHAF vs PBIGF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PBIGF has a market cap of 90.9M. Regarding current trading prices, FPHAF is priced at $3.30, while PBIGF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PBIGF's P/E ratio is -7.62. In terms of profitability, FPHAF's ROE is N/A, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, FPHAF is less volatile compared to PBIGF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check PBIGF's competition here
FPHAF vs MCURF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, FPHAF is priced at $3.30, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas MCURF's P/E ratio is -16.90. In terms of profitability, FPHAF's ROE is N/A, compared to MCURF's ROE of -1.02%. Regarding short-term risk, FPHAF is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check MCURF's competition here
FPHAF vs ATGGF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ATGGF has a market cap of 79.4M. Regarding current trading prices, FPHAF is priced at $3.30, while ATGGF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ATGGF's P/E ratio is N/A. In terms of profitability, FPHAF's ROE is N/A, compared to ATGGF's ROE of -0.76%. Regarding short-term risk, FPHAF is less volatile compared to ATGGF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check ATGGF's competition here
FPHAF vs PRNAF Comparison July 2025
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PRNAF has a market cap of 79M. Regarding current trading prices, FPHAF is priced at $3.30, while PRNAF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PRNAF's P/E ratio is -0.30. In terms of profitability, FPHAF's ROE is N/A, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, FPHAF is less volatile compared to PRNAF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check PRNAF's competition here